We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The North American Pancreatitis Study (NAPS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01545167
First Posted: March 6, 2012
Last Update Posted: September 15, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
David Whitcomb, University of Pittsburgh
February 29, 2012
March 6, 2012
September 15, 2017
September 2008
June 2014   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01545167 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The North American Pancreatitis Study
The North American Pancreatitis Study
This study will investigate several genes and other factors measured in the blood that may cause recurrent acute pancreatitis and chronic pancreatitis. No treatment is offered as part of this study. Subjects have one single visit to provide a blood sample for genetic testing and to answer a questionnaire. Subjects are not given results of genetic testing. The study is currently enrolling African American subjects and controls only.
This study seeks to enroll African American people with and without pancreatitis. There is only one study visit to obtain consent, a blood sample and complete a questionnaire. Subjects must be patients of a participating center; controls must present to a participating center for enrollment.
Observational
Observational Model: Case-Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Blood samples and extracted biomarkers and genetic material.
Non-Probability Sample
people with and without pancreatitis
Pancreatitis
Genetic: blood sampling
blood samples obtained to extract biomarkers and dna for analysis, questionnaires
  • African Americans with pancreatitis
    pancreatitis
    Intervention: Genetic: blood sampling
  • African Americans without Pancreatitis controls
    people without pancreatitis
    Intervention: Genetic: blood sampling
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2980
June 2014
June 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

African American

pancreatitis patients who are at least 14 years of age with a diagnosis of acute or chronic pancreatitis

  • controls who do not have pancreatitis and must be at least 18 years of age

Exclusion Criteria:

  • unable or unwilling to sign informed consent
Sexes Eligible for Study: All
14 Years to 100 Years   (Child, Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01545167
DK 061451
NAPS2-AS ( Other Grant/Funding Number: R01 DK077906 )
Yes
Not Provided
Not Provided
David Whitcomb, University of Pittsburgh
University of Pittsburgh
Not Provided
Not Provided
University of Pittsburgh
September 2017